Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 10,042.2%.

ASSET	% RETURN
Regencell Bioscience (RGC)	10,042.22%
CannBioRx Life Sciences (ATNFW)	4,287.76%
DeFi Development (DFDV)	2,277.77%
WW International, Inc Common Stock (WW)	2,266.41%
HCM II Acquisition (HONDW)	2,055.17%
Blue Gold Limited Warrant (BGLWW)	1,725.5%
Oncology Institute (TOIIW)	1,460.71%
Zepp Health (ZEPP)	1,451.15%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	1,368.89%
Diginex Limited Ordinary Shares (DGNX)	1,343.66%
BT Brands Inc Warrant (BTBDW)	1,340.53%
FiEE (FIEE)	1,234.95%
CEA Industries (VAPEW)	1,108.05%
CEA Industries (BNCWW)	1,040.94%
Oncology Institute (TOI)	1,040.52%
K Wave Media (KWMWW)	1,035.92%
USA Rare Earth (USARW)	1,034%
Asset Entities Inc Class B Common Stock (ASST)	1,018%
Abivax SA American Depositary Shares (ABVX)	1,000.83%
Webull Corporation Warrants (BULLW)	930.51%
TMC the metals company Inc Warrants (TMCWW)	852.74%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	837.64%
Global Interactive Technologies (GITS)	800.41%
Above Food Ingredients Inc Warrants (ABVEW)	775.91%
Protagenic Therapeutics (PTIXW)	746.15%